CMVLF
Price
$4.50
Change
-$0.54 (-10.71%)
Updated
Nov 19 closing price
Capitalization
485.14M
Intraday BUY SELL Signals
SLN
Price
$6.14
Change
-$0.13 (-2.07%)
Updated
Dec 24 closing price
Capitalization
318.83M
82 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CMVLF vs SLN

Header iconCMVLF vs SLN Comparison
Open Charts CMVLF vs SLNBanner chart's image
Cellectis Romainville
Price$4.50
Change-$0.54 (-10.71%)
Volume$2K
Capitalization485.14M
Silence Therapeutics
Price$6.14
Change-$0.13 (-2.07%)
Volume$158.98K
Capitalization318.83M
CMVLF vs SLN Comparison Chart in %
CMVLF
Daily Signal:
Gain/Loss:
SLN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CMVLF vs. SLN commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMVLF is a Hold and SLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (CMVLF: $4.50 vs. SLN: $6.14)
Brand notoriety: CMVLF and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMVLF: 180% vs. SLN: 61%
Market capitalization -- CMVLF: $485.14M vs. SLN: $318.83M
CMVLF [@Biotechnology] is valued at $485.14M. SLN’s [@Biotechnology] market capitalization is $318.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMVLF’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • CMVLF’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, both CMVLF and SLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMVLF’s TA Score shows that 2 TA indicator(s) are bullish while SLN’s TA Score has 3 bullish TA indicator(s).

  • CMVLF’s TA Score: 2 bullish, 3 bearish.
  • SLN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CMVLF is a better buy in the short-term than SLN.

Price Growth

CMVLF (@Biotechnology) experienced а 0.00% price change this week, while SLN (@Biotechnology) price change was -1.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

SLN is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMVLF($485M) has a higher market cap than SLN($319M). CMVLF YTD gains are higher at: 200.000 vs. SLN (-10.756). CMVLF has higher annual earnings (EBITDA): -6.07M vs. SLN (-81.06M). CMVLF has more cash in the bank: 190M vs. SLN (102M). SLN has less debt than CMVLF: SLN (182K) vs CMVLF (92.8M). CMVLF has higher revenues than SLN: CMVLF (75.3M) vs SLN (25.8M).
CMVLFSLNCMVLF / SLN
Capitalization485M319M152%
EBITDA-6.07M-81.06M7%
Gain YTD200.000-10.756-1,859%
P/E RatioN/AN/A-
Revenue75.3M25.8M292%
Total Cash190M102M186%
Total Debt92.8M182K50,989%
FUNDAMENTALS RATINGS
CMVLF: Fundamental Ratings
CMVLF
OUTLOOK RATING
1..100
46
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
26

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMVLFSLN
RSI
ODDS (%)
Bullish Trend 4 days ago
31%
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
27%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
23%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
88%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CMVLF
Daily Signal:
Gain/Loss:
SLN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OMMSF0.06N/A
N/A
Omineca Mining & Metals Ltd.
YOKEY64.24N/A
N/A
Yokogawa Electric Co.
CLLKF2.11N/A
N/A
BICO GROUP AB
ATAZF15.25N/A
N/A
Atea ASA
BCLYF6.32-0.04
-0.71%
Barclays Plc

CMVLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMVLF has been closely correlated with CLLS. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if CMVLF jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMVLF
1D Price
Change %
CMVLF100%
N/A
CLLS - CMVLF
78%
Closely correlated
+0.21%
SLN - CMVLF
41%
Loosely correlated
-2.07%
ALDX - CMVLF
39%
Loosely correlated
+4.55%
CLGN - CMVLF
37%
Loosely correlated
N/A
ASPHF - CMVLF
36%
Loosely correlated
N/A
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
-2.07%
CLLS - SLN
43%
Loosely correlated
+0.21%
TSHA - SLN
39%
Loosely correlated
+3.50%
CMVLF - SLN
38%
Loosely correlated
N/A
CLDX - SLN
37%
Loosely correlated
+0.94%
TNGX - SLN
36%
Loosely correlated
+1.99%
More